Among the keywords included in the search were Mounjaro, Wegovy, Ozempic, and Trulicity
Conditions that prevent use include a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, a history of severe pancreatitis, pregnancy, and active gallbladder disease
Your healthcare provider will help you find treatments that reduce how much AS symptoms interfere with your day-to-day routine
On April 1, 2026, the FDA approved Foundayo (orforglipron) from Eli Lillythe first oral small-molecule GLP-1 receptor agonist for chronic weight management
For readers comparing approved incretin options, Mounjaro and Type 2 Diabetes gives background on tirzepatide in clinical care